US Equities Analysis

TMO — Thermo Fisher Scientific

TMO TMO Price Chart

Thermo Fisher Scientific (TMO) is a life sciences tools & services company in the Health Care sector. Listed on the NASDAQ, Thermo Fisher Scientific is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $482.04.

Key Metrics & Risk

Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).

MetricValue
Latest Price$482.04
Latest Date2026-06-10
Expected Return (Annualized)4.67%
Risk / Std Dev (Annualized)27.20%
Sharpe Ratio (rf=4.5%)0.01

S&P 500 Context

  • Sector: Health Care
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Index: S&P 500 Component

Risk/Return Profile

The stock shows an annualized expected return of 4.67% with an annualized volatility of 27.20%. The Sharpe ratio of 0.01 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.

Modern Portfolio Theory Positioning

This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.

Fundamentals

MetricValue
Market Cap179.14B
Enterprise Value219.17B
Trailing P/E26.53
Forward P/E17.68
Price to Book3.4
Price to Sales3.96
EV/Revenue4.85
EV/EBITDA19.4

| Profitability | | | Profit Margin | 15.15% | | Operating Margin | 17.89% | | ROE | 13.52% | | ROA | 5.0% |

| Growth | | | Revenue Growth | 6.2% | | Earnings Growth | 11.3% |

| Dividend | | | Dividend Yield | 39.0% | | Payout Ratio | 9.68% | | 5Y Avg Yield | 26.0% |

| Financial Health | | | Total Revenue | 45.2B | | Total Debt | 43.16B | | Total Cash | 3.26B | | Free Cash Flow | 5.52B | | Operating Cash Flow | 8.29B |

| Price & Technical | | | 52W High | $643.99$ | | 52W Low | $385.46$ | | 50-Day Avg | $479.66$ | | 200-Day Avg | $526.51$ | | Beta | 0.87 | | Shares Outstanding | 0.37B | | Float Shares | 0.37B | | Insider Holdings | 0.15% | | Institutional Holdings | 94.31% | | Short Ratio | 1.83 | | Short % of Float | 1.26% |

| Analyst Targets | | | Target High | $750.0$ | | Target Low | $490.0$ | | Target Mean | $602.76$ | | Target Median | $600.0$ | | # of Analysts | 25 | | Recommendation | strong_buy |

Disclaimer

This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.

us-equity stock equity tmo health-care life-sciences-tools--services nasdaq